Related references
Note: Only part of the references are listed.Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis
Tobias Baeuerle et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone
Thomas Levin Andersen et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots
Willem J. M. Mulder et al.
ANGIOGENESIS (2009)
Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases
Theresa A. Guise
GENES & DEVELOPMENT (2009)
Pharmacological Inhibition of Integrin αvβ3 Aggravates Experimental Liver Fibrosis and Suppresses Hepatic Angiogenesis
Eleonora Patsenker et al.
HEPATOLOGY (2009)
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency
Tom Mikkelsen et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
Andrew R. Reynolds et al.
NATURE MEDICINE (2009)
The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
Gian Carlo Alghisi et al.
PLOS ONE (2009)
αvβ3 integrin and angiogenesis: a moody integrin in a changing environment
Kairbaan Hodivala-Dilke
CURRENT OPINION IN CELL BIOLOGY (2008)
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme
David A. Reardon et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
David A. Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI
Tobias Baeuerle et al.
NEOPLASIA (2008)
CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells
Qiming Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Alpha-v integrins as therapeutic targets in oncology
Jeffrey A. Nemeth et al.
CANCER INVESTIGATION (2007)
Involvement of αvβ3 integrins in osteoclast function
Ichiro Nakamura et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2007)
Tumor ανβ3 integrin is a therapeutic target for breast cancer bone metastases
Yingshe Zhao et al.
CANCER RESEARCH (2007)
Effect of the angiogenesis inhibitor cilengitide (EMD 121974) on glioblastoma growth in nude mice
Shinya Yamada et al.
NEUROSURGERY (2006)
Integrin αVβ3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models
Jeffrey M. Albert et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Antiangiogenic combination tumor therapy blocking αv-integrins and VEGF-receptor-2 increases therapeutic effects in vivo
Sebastian Strieth et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Tumor-specific expression of alpha v beta 3 integrin promotes spontaneous metastasis of breast cancer to bone
EK Sloan et al.
BREAST CANCER RESEARCH (2006)
Inhibition of αvβ3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy
A Abdollahi et al.
CLINICAL CANCER RESEARCH (2005)
Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein
T Bäuerle et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
αvβ integrins play an essential role in BMP-2 induction of osteoblast differentiation
CF Lai et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Increased primary tumor growth in mice null for β3- or β3/β5-integrins or selectins
D Taverna et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Bone imaging in metastatic breast cancer
T Hamaoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A small molecule antagonist of the alpha(v)beta(3) integrin suppresses MDA-MB-435 skeletal metastasis
JF Harms et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Bone sialoprotein, matrix metalloproteinase 2, and αvβ3 integrin in osteotropic cancer cell invasion
A Karadag et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Inhibition of alpha v beta 3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases
JA Nemeth et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating αvβ5 vitronectin receptor cell surface expression
I Silvestri et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand
JP Xiong et al.
SCIENCE (2002)
Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling
BP Eliceiri et al.
JOURNAL OF CELL BIOLOGY (2002)
Inhibition of the alpha-ν integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo
MA Buerkle et al.
BRITISH JOURNAL OF CANCER (2002)
Enhanced pathological angiogenesis in mice lacking beta(3) integrin or beta(3) and beta(5) integrins
LE Reynolds et al.
NATURE MEDICINE (2002)
Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha v integrin antagonist
TJ MacDonald et al.
NEUROSURGERY (2001)
Tumor necrosis factor alpha regulates alpha(v)beta(5) integrin expression by osteoclast precursors in vitro and in vivo
M Inoue et al.
ENDOCRINOLOGY (2000)
Share Paper
